Journal
British Journal of Cancer
Publication Date
2019
Volume
121
Issue
3
First Page
211
Last Page
217
Document Type
Open Access Publication
DOI
10.1038/s41416-019-0504-8
Rights and Permissions
Morgensztern, D., Rose, M., Waqar, S.N. et al. RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer. Br J Cancer 121(3): 211–217 (2019). https://doi.org/10.1038/s41416-019-0504-8. www.bjcancer.com © The Author(s), under exclusive licence to Cancer Research UK 2019 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Morgensztern, Daniel; Rose, Michal; Waqar, Saiama N; Morris, John; Ma, Patrick C; Reid, Thomas; Brzezniak, Christina E; Zeman, Karen G; Padmanabhan, Arvinda; Hirth, JoAnn; I Spira, Alexander; Trepel, Jane B; and Padda, Sukhmani K, "RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer." British Journal of Cancer. 121, 3. 211 - 217. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8841
